Increasing Transparency at the US Food and Drug Administration

被引：1
|
作者：
Steinbrook, Robert [1 ]
机构：
[1] Univ Calif San Francisco, Sch Med, 505 Parnassus Ave,Ste M1180,Box 0124, San Francisco, CA 94143 USA
来源：
JAMA INTERNAL MEDICINE | 2019年 / 179卷 / 08期
关键词：
D O I：
10.1001/jamainternmed.2019.1194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1146 / 1147
页数：2
相关论文
共 50 条
  • [41] Product Exclusivity Granted by the US Food and Drug Administration
    Novack, Gary D.
    OCULAR SURFACE, 2016, 14 (01): : 74 - 76
  • [42] The US Food and Drug Administration and probiotics: Regulatory categorization
    Degnan, Frederick H.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 : S133 - S136
  • [43] The history and contemporary challenges of the US Food and Drug Administration
    Borchers, Andrea T.
    Hagie, Frank
    Keen, Carl L.
    Gershwin, M. Eric
    CLINICAL THERAPEUTICS, 2007, 29 (01) : 1 - 16
  • [44] Regulatory Action on Rosiglitazone by the US Food and Drug Administration
    Woodcock, Janet
    Sharfstein, Joshua M.
    Hamburg, Margaret
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (16): : 1489 - 1491
  • [45] US Food and Drug Administration bill signed into law
    Rovner, J
    LANCET, 1997, 350 (9092): : 1690 - 1690
  • [46] US Food and Drug Administration Activities to Address Chemical Contaminants in Food
    South, Paul
    ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 243 - 243
  • [47] Methodology for monitoring toxic elements in food by the US Food and Drug Administration
    Mindak, William R.
    Cheng, John
    Capar, Stephen G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 211 - 211
  • [48] US Food and Drug Administration Systematic Review of Drug Exposure Registries
    Zhao, Yanling
    Major, Jacqueline M.
    Moeny, David
    Wang, Cunlin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 314 - 315
  • [49] Adverse drug events in children: The US food and drug administration perspective
    Rodriguez, W
    Roberts, R
    Murphy, D
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (10): : 711 - 723
  • [50] Evidence Supporting US Food and Drug Administration Drug Safety Communications
    Ross, Joseph S.
    JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1592 - 1592
12345